Ayr Wellness Inc. (OTCMKTS:AYRWF) Receives Average Recommendation of “Buy” from Brokerages

Ayr Wellness Inc. (OTCMKTS:AYRWFGet Rating) has been assigned an average rating of “Buy” from the seven ratings firms that are covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $48.55.

AYRWF has been the topic of a number of analyst reports. Needham & Company LLC decreased their price target on Ayr Wellness from $28.00 to $21.00 and set a “buy” rating on the stock in a research note on Friday, March 18th. Zacks Investment Research raised Ayr Wellness from a “sell” rating to a “hold” rating in a research note on Wednesday. Cantor Fitzgerald decreased their price target on Ayr Wellness from $17.50 to $13.30 and set a “neutral” rating on the stock in a research note on Friday, March 18th. Finally, Canaccord Genuity Group decreased their price target on Ayr Wellness from C$57.00 to C$40.00 and set a “buy” rating on the stock in a research note on Friday, March 18th.

Shares of OTCMKTS:AYRWF traded up $0.16 on Friday, hitting $4.92. The company’s stock had a trading volume of 275,333 shares, compared to its average volume of 307,852. The company has a 50-day simple moving average of $10.17 and a 200 day simple moving average of $13.96. Ayr Wellness has a 1 year low of $4.61 and a 1 year high of $31.87. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.13 and a current ratio of 1.75.

Ayr Wellness (OTCMKTS:AYRWFGet Rating) last announced its quarterly earnings data on Thursday, March 17th. The company reported ($0.27) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.22) by ($0.05). The firm had revenue of $111.77 million for the quarter, compared to analysts’ expectations of $105.55 million. Ayr Wellness had a negative net margin of 4.74% and a negative return on equity of 6.15%. As a group, equities analysts predict that Ayr Wellness will post -0.89 EPS for the current fiscal year.

About Ayr Wellness (Get Rating)

Ayr Wellness Inc, a vertically-integrated cannabis multi-state operator, cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. The company's cannabis and cannabis products include concentrates, edibles, and vaporizer products. It also provides administrative, consulting, and operations support services to licensed cannabis companies.

Further Reading

Analyst Recommendations for Ayr Wellness (OTCMKTS:AYRWF)

Receive News & Ratings for Ayr Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ayr Wellness and related companies with MarketBeat.com's FREE daily email newsletter.